PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20514517-0	2010	Pyrrolidine dithiocarbamate activates p38 MAPK and protects brain endothelial cells from apoptosis: a mechanism for the protective effect in stroke?	pyrrolidine dithiocarbamic acid	0-27	mitogen-activated protein kinase 14	Mus musculus	38-41	
32240662-6	2020	Pyrrolidine dithiocarbamate and SB203580 were used to block NF-kappaB and p38 MAPK respectively, to explore the possible molecular mechanisms.	pyrrolidine dithiocarbamic acid	0-27	mitogen-activated protein kinase 14	Mus musculus	74-82	
24379122-5	2014	Furthermore, tmTNF-alpha caused p38 phosphorylation and NF-kappaB activation, whereas inhibition of NF-kappaB or p38 with an inhibitor pyrrolidine dithiocarbamate or SB203580 abrogated tmTNF-alpha-mediated increased suppression of lymphocyte proliferation by MDSCs.	pyrrolidine dithiocarbamic acid	135-162	mitogen-activated protein kinase 14	Mus musculus	113-116	
23588388-9	2013	The treatment of OBs with SB203580 (an inhibitor of p38 MAPK) and pyrrolidine dithiocarbamate (PDTC, an inhibitor of NF-kappaB) prior to stimulation with SAS significantly inhibited the phosphorylation and mRNA expression of p38 MAPK and NF-kappaB p65, simultaneously reducing the release of MBD-14.	pyrrolidine dithiocarbamic acid	66-93	mitogen-activated protein kinase 14	Mus musculus	225-233